NFE2L2 and cancer: For similar reasoning, it is not safe to draw conclusions for normal metabolism from a recent study by Mitsuishi et al. showing that Nrf2 redirects glucose and glutamine into anabolic pathways [81], although this study has surely a big impact on the elucidation of mechanisms of metabolic reprogramming in cancer cells.